Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Valentino joins Alpharma

This article was originally published in The Tan Sheet

Executive Summary

Michael Valentino steps into newly created role of president & COO of Global Human Pharmaceuticals and exec VP of firm effective Oct. 15. He reports to Alpharma President & CEO Ingrid Wiik, who says Valentino will help to develop firm's "global growth opportunities by creating and expanding key strategic alliances [and] developing a strong global new product pipeline." Valentino most recently served as Novartis Consumer Health global head/exec VP and also was chairman of CHPA's board (1"The Tan Sheet" Jan. 7, 2002, p. 3)...

You may also be interested in...



Novartis Consumer Health Changes Leave CHPA Without A Chair

Novartis exec Michel Orsinger has taken the reigns as head of the firm's consumer health global OTC division, effective Jan. 1

COVID-19 Lockdown: India Pharma Manufacturing Limps Along Amid Challenges

Pharma manufacturing is operating well below normal levels in India, disrupted by labor absenteeism and supply chain issues amid the ongoing lock-down in the country, though the government is actively engaged in addressing bottlenecks. A speedy recovery is vital not just for domestic supplies.

Moderna Stands Alone With Single-Antigen Approach To COVID-19 Vaccine

Moderna is pursuing a single-antigen strategy even though some of its mRNA vaccines have included multiple antigens; the SARS-CoV-2 spike protein likely provides the best antigen for developing immunity against the virus.

Topics

UsernamePublicRestriction

Register

PS094688

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel